Loopworm raises $3.25M for sustainable protein tech

Scaling up #biomanufacturing remains a daunting task for startups in a challenging funding environment, says India-based Symbiotec Pharmalab Pvt. Ltd.. But new capacity it is bringing online can help startups in everything from alt proteins to nutraceuticals cross the valley of death. A leading manufacturer of Active Pharmaceutical Ingredients (APIs), Symbiotec is now offering its services as a CDMO to firms in biomaterials, nutraceuticals, specialty chemicals, and alt proteins using bacteria, yeast, fungi and algae, says US investments director Prakash Sawlani. The firm has four new 100,000-liter fermenters at its facility in Ujjaiin in Madhya Pradesh, India, with extensive downstream processing capabilities including filtration, extraction, crystallization and spray-drying. It can also work with partners at pilot scale with 2,000-L and 20,000-L fermenters for smooth tech transfer at the Ujjaiin site, which is powered by renewables, said Sawlani. It can also add additional capacity at the site via co-investment, building and commissioning equipment quickly and cost-effectively, Sawlani claimed. “We’re talking about capital expenditure that is a third to a quarter of US and European benchmarks.” As Symbiotec is an owner-operator with an in-house engineering team, he said, “Decisions are quick, scope is clear, and approvals don’t lag.” #foodtech #agtech #ferementation #bioproducts #biotech #syntheticbiology #precisionfermentation #biomassfermentation

A pivotal shift in the alternative protein sector reveals that market strategy and application specificity are crucial to commercial success, even when the core technology (insect meal) encounters scaling hurdles. Biotechnology is a powerful case study in vertical integration and value-added product focus. Success lies in the use of new feed ingredients, such as insect meal, and achieving commercial viability in combining these ingredients to produce a high-performance, cost-competitive final feed product.  #Insect_Feed #Biotechnology_Feed

#NewIndia is redefining global bio-manufacturing with 🔬 Innovation-led growth 🧪 Strong R&D capabilities 👩🔬 Deep pool of scientific talent Invest in India’s thriving #biotech ecosystem,visit: https://lnkd.in/gnZg4UJt #InvestInIndia #InvestIndia #IndiaOpportunity #Biotechnology #TechForGrowth #Bioeconomy #MakeInIndia #BioTechStartups Department for Promotion of Industry and Internal Trade | Department of Commerce | Ministry of Commerce and Industry, Government of India | Make In India | Department of Science & Technology, Government of India | Department of Biotechnology | DBT BIRAC | Startup India Source: https://lnkd.in/gU6FSsRz https://lnkd.in/e_A2QVNG

💥“The new food era is here. For it to scale, all these pieces—research, innovation, production—need to come together,” says Dr. Rajesh Gokhale, Secretary for the Department of Biotechnology, discussing the tremendous opportunity for cultivated meat in India. https://lnkd.in/eicn8jFB GFI India’s Chandana Tekkatte and Astha Gaur sat down with Udit Hinduja to unpack the science behind cultivated meat, the evolution of the R&D ecosystem, and the regulatory pathways to bring it to market. 🥩 Read on as ThePrint deep dives into how policies like #BioE3 are enabling translational research, startups like ClearMeat® and Biokraft Foods are driving progress, and India’s biotechnology strengths are providing a global edge. Siddharth Manvati (Ph.D.), Kamalnayan Tibrewal #cultivatedmeat #smartprotein #alternativeprotein #bioeconomy #biotech #foodtech #futureoffood

InnoFalcon has achieved a world-first: Vegan artificial cultivation of O.sinensis — unlocking sustainable access to one of nature’s rarest bioactive resources. Our patented technology powers TYCOS-1™, a next-generation pain relief cream that merges biotechnology with traditional wisdom. We’re now open to investors and strategic partners to scale this innovation globally. 🔗 www.innofalcon.com #InnoFalcon #Biotech #Cordyceps #Innovation #VeganBiotech #InvestInScience #SustainableHealth #TYCOS1

🚀 India has steadily climbed the manufacturing complexity curve – from its proven strength in chemistry-led platforms to what we see as the next frontier: bio-manufacturing. At Eight Roads Ventures, we have consistently backed companies with manufacturing at their core, across both chemical and biological domains, and most recently with Laurus Bio 🌏 As the global spotlight turns to scalable, sustainable, and safer alternatives, India’s rapidly advancing bio-manufacturing ecosystem is well positioned to lead this transformation. In the article below, Siddharth . from our healthcare investment team, expands on how this is being demonstrated by the progress being made at Laurus Bio Link to article in comments below⬇️ #healthcare #biomanufacturing #LaurusBio #LaurusLabs

We're excited to share our latest #pressrelease highlighting the transformative impact of #microbiomesequencing in #healthcare, #agriculture, and #environmentalscience. With a robust market growth rate of 19.3% CAGR, the surge in #sequencingtechnology is opening new avenues for #personalizeddiagnostics and #drugdevelopment. Supporting innovation, leading companies and #startups, including renowned names and emerging stars like Pendulum Therapeutics, Microba Life Sciences, and BiomeSense are paving the way towards more accessible and effective treatments. Read more in our latest press release - https://prn.to/3VQSaLG #BiotechInnovation #HealthcareInnovation #Biotech #Healthcare #MarketTrends #MarketGrowth #MarketResearch #BCCResearch

German biotechnology company AMSilk | Biogenius Materials raised €52 million in financing to advance industrial-scale production of its silk-based protein biomaterials, with €30 million in equity and €22 million in convertible bonds from lead investor ATHOS alongside MIG Capital and Novo Holdings. The company leverages genetically modified microorganisms to produce silk proteins that are processed into various forms including powders, hydrogels, fibers, and coatings. The protein product offers a biodegradable and microplastic-free alternative for textile, automotive, and consumer care applications. AMSilk has established long-term manufacturing agreements with industrial partners, including Evonik and Ajinomoto, enabling dedicated production facilities to operate at commercial scale using the company's proprietary biotechnology platform. The funding will support capacity expansion to meet growing demand while strengthening supply chain infrastructure and industrial processes. This investment validates AMSilk's transition to commercial manufacturing as it aims to be a leader in alternatives to conventional synthetic materials. #cellag #futureoffood #cultivatedmeat #cellbasedmeat #precisionfermentation

🔥 Big news for ClearMeat® and for #India! At World Food India 2025, We’ve just signed an MoU with National Institute of Food Technology Entrepreneurship and Management, Kundli (NIFTEM-K) (MOFPI Government of India) to launch a joint venture that will take #India to the global stage in #AlternativeProtein. 🌍 This is more than a partnership — it’s a launch pad to conquer world markets and position India as a global leader in cultivated & sustainable food innovation, under the spirit of the #MakeinIndia initiative.✨ At ClearMeat®, our team has been working hand-in-hand with the Govt. of India — from building manufacturing strategies to shaping policy frameworks — and today marks a giant leap forward. 💡 Special Thanks to Parul Soni Manvati We’re not just building a company. We’re building an industry of the future — one that is ethical, sustainable, and proudly #MadeinIndia, for the World. 🌱🥩 The journey has just begun. 🚀 #AlternativeProtein #CultivatedMeat #MakeInIndia #FoodTech #Innovation #GlobalLeadership Mistletoe, Inc. , Atsushi Taira Naho Shigeta Brinc Manav Gupta Brinc India Artesian (Alternative Investments) BITS BioCyTiH Foundation Gene Kim ANIL WALI Anwar Ul Haque Niloo Srivastava FT Prabodh S. Halde ( PhD) FT Chinmayee Deulgaonkar Jane Karkada Sandiip Bhammer Dheeraj Talreja Sid Jain Hemendra Mathur Arise Ventures Harinder Oberoi DP World Mahip Singh CellAgri ProVeg International YourStory Media Green Queen Media Bruce Friedrich Albrecht Wolfmeyer

🚀 What if your blood thinner didn’t come from pigs? Meet ExCulture, a biotech startup on a mission to revolutionize how we produce complex medicines. 💡 Today, one of the most widely used anticoagulants, heparin, is still made from pig intestines. To meet global demand, over 70% of the supply comes from China, extracted from hundreds of millions of animals each year. But with growing concerns about supply chain fragility and shortages, the need for a safer, more resilient solution is urgent. ExCulture is changing that with a more sustainable bioprocess based on fermentation technology. Backed by our industrial biotech fund, they’re scaling a future-proof solution to a global health challenge. 🌍💉 Aisling Foley Ilaria Poledri Damien van der Bijl Daniela Arruda Costa Rob van der Meij Ludwig Goris Wouter Van de Putte